Dehaze
AI-driven chronic disease detection
About
Dehaze is a Munich-based healthtech startup founded in 2023 that develops an AI platform for early detection of chronic diseases. Its technology autonomously analyzes healthcare data to identify chronic conditions earlier and more accurately, aiming to improve patient outcomes and reduce healthcare costs. The company operates on a B2B model, partnering with healthcare providers and payers. Dehaze raised €3.2 million in seed funding led by YZR Capital and DN Capital as part of the Techstars 2025 cohort, positioning itself at the forefront of healthcare AI innovation.
Products
- AI Chronic Disease Detection Platform
Market research & competitive positioning
Source-backed TAM / SAM / SOM sizing, displacement analysis, and an interactive peer positioning map for Dehaze — available to members.
